Infliximab therapy balances regulatory T cells, tumour necrosis factor receptor 2 (TNFR2) expression and soluble TNFR2 in sarcoidosis

A Verwoerd, D Hijdra, A D M Vorselaars, H A Crommelin, C H M van Moorsel, J C Grutters, A M E Claessen

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Infliximab therapy balances regulatory T cells, tumour necrosis factor receptor 2 (TNFR2) expression and soluble TNFR2 in sarcoidosis'. Together they form a unique fingerprint.

Immunology and Microbiology